Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Dapagliflozin has shown clinical effectiveness in some of the same metabolic processes that are affected by COVID-19, but can it help treat patients who have contracted the virus?
Read More »ADA 2021: Dapagliflozin Use in Patients with COVID-19
ADA 2021: Risk Reduction of Type 2 Diabetes after Gestational Diabetes
The prevalence of underdiagnosed prediabetes and type 2 diabetes mellitus (T2DM) plays an active role in gestational diabetes.
Read More »ADA 2021: Infusion Set Survival and Performance of Medtronic Extended-Wear Infusion Set
Real-world data for the Medtronic Extended-Wear Infusion Set revealed at the 81st American Diabetes Association scientific session.
Read More »ADA 2021: Effectiveness of Liraglutide and Insulin Based on GRADE Study
The GRADE Study is the most comprehensive study comparing multiple diabetic medications to assess efficacy in type 2 diabetes. So which drug therapy reigned supreme?
Read More »ADA 2021: Economic Benefits of Initiating Empagliflozin vs. GLP-1 Receptor Agonist
The study evaluates the healthcare cost associated with two principal therapies for patients with type 2 diabetes.
Read More »Prevent Infection Transmission During Assisted Glucose Monitoring
Several warnings have been issued by the CDC regarding unsafe practices that might result in the transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and other infectious diseases during assisted blood glucose monitoring and insulin administration.
Read More »ADA 81st Symposium: Tirzepatide a Novel GIP/GLP-1 Agonist-Current Update
Results for SURPASS-1 and SURPASS-2 trials of tirzepatide in patients with type 2 diabetes inadequately controlled with diet and exercise alone were presented at this year’s virtual symposium. If you weren’t able to attend the symposium, you can read about the trials here.
Read More »Can HbA1c Variability Predict Diabetic Complications?
A study was conducted to assess if HbA1c variability impacts the incidence of diabetic complications, all-cause and cardiovascular mortality.
Read More »Oily Fish Lower Risk of Diabetes
People who reported two or more servings per week of oily fish consumption had a 22% lower risk of developing type 2 diabetes.
Read More »Can Diabetes Affect Your Ability to Exercise in Hot Weather?
By Sheri Colberg, PhD
The arrival of summer brings to mind visions of people having fun in the sun and recreating on the beach. Still, hotter weather also creates more significant risks related to dehydration and heat stress for people who are physically active outdoors. Aging by itself negatively affects the body's ability to dissipate heat in both dry and humid environments, but having diabetes further increases the risk of developing heat stress during outdoor activities, especially when hot and humid.